PCSK9 and LDL cholesterol: unravelling the target to design the bullet.

Abstract excerpt

Gain-of-function mutations within proprotein convertase subtilisin kexin type 9 (PCSK9) are linked to familial autosomal dominant hypercholesterolaemia, a disease characterized by elevated plasma concentrations of cholesterol associated with low-density lipoproteins (LDLs). Conversely, PCSK9 loss-of-function mutations result in low levels of LDL cholesterol (LDLC) and protect against coronary heart disease....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cholesterol, LDL
• Share to Hyperlipoproteinemia Type II
• Share to Mice, Knockout